Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ceribell (CBLL) Cash & Equivalents (2023 - 2026)

Ceribell filings provide 4 years of Cash & Equivalents readings, the most recent being $45.3 million for Q1 2026.

  • On a quarterly basis, Cash & Equivalents fell 70.49% to $45.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $45.3 million, a 70.49% decrease, with the full-year FY2025 number at $40.5 million, down 79.18% from a year prior.
  • Cash & Equivalents hit $45.3 million in Q1 2026 for Ceribell, up from $40.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $194.4 million in Q4 2024 to a low of $14.1 million in Q3 2024.
  • Median Cash & Equivalents over the past 4 years was $40.3 million (2025), compared with a mean of $68.2 million.
  • Biggest five-year swings in Cash & Equivalents: surged 463.47% in 2024 and later plummeted 79.18% in 2025.
  • Ceribell's Cash & Equivalents stood at $34.5 million in 2023, then surged by 463.47% to $194.4 million in 2024, then plummeted by 79.18% to $40.5 million in 2025, then increased by 11.8% to $45.3 million in 2026.
  • The last three reported values for Cash & Equivalents were $45.3 million (Q1 2026), $40.5 million (Q4 2025), and $23.7 million (Q3 2025) per Business Quant data.